Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02555657
Brief Title: Study of Single Agent Pembrolizumab (MK-3475) Versus Single Agent Chemotherapy for Metastatic Triple Negative Breast Cancer (MK-3475-119/KEYNOTE-119)

First Submitted : September 18, 2015
First Submitted that Met QC Criteria : September 18, 2015
First Posted : September 21, 2015 (Estimate)

Results First Submitted : March 27, 2020
Results First Submitted that Met QC Criteria : April 22, 2020
Results First Posted : May 4, 2020

Last Update Submitted that Met QC Criteria : December 9, 2020
Last Update Posted : January 8, 2021